Amylyx Pharmaceuticals, Inc.
AMLX
Revenue
-665.00k
▼-1.08M▼-259.86%
3 Months ChangeAssets
193.63M
▼-57.08M▼-22.77%
3 Months ChangeLiabilities
28.87M
▼-25.64M▼-47.04%
3 Months ChangeFree Cash Flow
-556.00k
▲4.77M▲89.55%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-17
Form 8-K
ID: 0001193125-24-238572
2024-08-08
Form 10-Q
ID: 0000950170-24-093311
2024-08-08
Form 8-K
ID: 0000950170-24-093304
2024-07-10
Form 8-K
ID: 0001193125-24-177000
2024-06-21
Form 8-K
ID: 0000950170-24-076339
2024-06-06
Form 8-K
ID: 0001193125-24-156050
2024-05-09
Form 10-Q
ID: 0000950170-24-056269
2024-05-09
Form 8-K
ID: 0000950170-24-056254
2024-04-10
Form 8-K
ID: 0001193125-24-091463
2024-04-04
Form 8-K
ID: 0001193125-24-086609